大島洸人 先生(平成24年卒業、必威体育_必威体育app-平台*官网生) 1st author の論文が、J Pharmacol Exp Ther 誌に掲載されました。
論文タイトル：Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.
論文タイトル：Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.